The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[({[(2S,3S,4R,5R)-5-(6-Chloro-4-{[(2-chlorophenyl)methyl]-amino}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)methyl]phosphonic Acid ID: ALA4782125
PubChem CID: 148018940
Max Phase: Preclinical
Molecular Formula: C18H20Cl2N5O6PS
Molecular Weight: 536.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=P(O)(O)CSC[C@H]1O[C@@H](n2ncc3c(NCc4ccccc4Cl)nc(Cl)nc32)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C18H20Cl2N5O6PS/c19-11-4-2-1-3-9(11)5-21-15-10-6-22-25(16(10)24-18(20)23-15)17-14(27)13(26)12(31-17)7-33-8-32(28,29)30/h1-4,6,12-14,17,26-27H,5,7-8H2,(H,21,23,24)(H2,28,29,30)/t12-,13-,14-,17-/m1/s1
Standard InChI Key: JAIAGXYPLMOWIL-VMUDFCTBSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
6.4921 -10.2273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9143 -9.6495 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
5.7028 -10.4388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3008 -9.3606 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.9097 -8.8136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3543 -8.5840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6911 -9.0641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9416 -9.8454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7629 -9.8454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0176 -9.0641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2472 -10.5087 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4615 -10.5087 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0495 -6.6140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6409 -7.3231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0495 -8.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8708 -8.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2794 -7.3231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8708 -6.6140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1255 -8.8136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4581 -9.2937 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7948 -8.8136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1009 -7.3230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5093 -6.6140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6409 -5.9008 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.3265 -6.6132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7324 -7.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5489 -7.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9576 -6.6130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5440 -5.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7289 -5.9073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3166 -5.2017 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.5239 -9.1072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1391 -9.4000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
6 10 1 0
9 11 1 6
8 12 1 6
7 5 1 1
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
19 20 2 0
20 21 1 0
15 21 1 0
16 19 1 0
22 23 1 0
17 22 1 0
13 24 1 0
10 21 1 1
23 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
30 31 1 0
4 32 1 0
32 2 1 0
2 33 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 536.33Molecular Weight (Monoisotopic): 535.0249AlogP: 2.23#Rotatable Bonds: 8Polar Surface Area: 162.85Molecular Species: ACIDHBA: 10HBD: 5#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.63CX Basic pKa: 1.12CX LogP: 0.58CX LogD: -1.21Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.21Np Likeness Score: -0.74
References 1. Du X,Moore J,Blank BR,Eksterowicz J,Sutimantanapi D,Yuen N,Metzger T,Chan B,Huang T,Chen X,Chen Y,Duong F,Kong W,Chang JH,Sun J,Zavorotinskaya T,Ye Q,Junttila MR,Ndubaku C,Friedman LS,Fantin VR,Sun D. (2020) Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production., 63 (18): [PMID:32865411 ] [10.1021/acs.jmedchem.0c01086 ]